Keywords: merck, co, cozaar, gets, approval, stroke, prevention

Merck & Co's Cozaar gets US approval for stroke prevention

Article | 31 March 2003

Print This

Merck & Co's angiotensin II receptor antagonist Cozaar (losartan) hasbecome the first and only antihypertensive to be approved in the USA ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in